Vertex Pharmaceuticals (VRTX) Net Cash Flow Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.37% |
| Dec 31, 2025 | -53.20% |
| Sep 30, 2025 | -27.22% |
| Jun 30, 2025 | -40.32% |
| Mar 31, 2025 | -53.26% |
| Dec 31, 2024 | -47.33% |
| Sep 30, 2024 | 42.85% |
| Jun 30, 2024 | -165.03% |
| Mar 31, 2024 | -77.79% |
| Dec 31, 2023 | -48.35% |
| Sep 30, 2023 | 23.83% |
| Jun 30, 2023 | -11.68% |
| Mar 31, 2023 | -65.31% |
| Dec 31, 2022 | 86.34% |
| Sep 30, 2022 | 68.86% |
| Jun 30, 2022 | 41.13% |
| Mar 31, 2022 | 49.23% |
| Dec 31, 2021 | 44.86% |
| Sep 30, 2021 | -13.27% |
| Jun 30, 2021 | -53.18% |
| Mar 31, 2021 | -0.85% |
| Dec 31, 2020 | 29.65% |
| Sep 30, 2020 | 74.61% |
| Jun 30, 2020 | 73.06% |
| Mar 31, 2020 | 66.79% |
| Dec 31, 2019 | -39.20% |
| Sep 30, 2019 | -2.35% |
| Jun 30, 2019 | 352.22% |
| Mar 31, 2019 | 60.75% |
| Dec 31, 2018 | 83.91% |
| Sep 30, 2018 | 70.34% |
| Jun 30, 2018 | -8.96% |
| Mar 31, 2018 | 99.77% |
| Dec 31, 2017 | 71.63% |
| Sep 30, 2017 | -31.25% |
| Jun 30, 2017 | 276.20% |
| Mar 31, 2017 | -8.24% |
| Dec 31, 2016 | 203.53% |
| Sep 30, 2016 | 32.67% |
| Jun 30, 2016 | -69.45% |
| Mar 31, 2016 | -1.09% |
| Dec 31, 2015 | -40.58% |
| Sep 30, 2015 | -87.78% |
| Jun 30, 2015 | 3.18% |
| Mar 31, 2015 | 30.13% |
| Dec 31, 2014 | -10.94% |
| Sep 30, 2014 | 52.63% |
| Mar 31, 2014 | -39.56% |
| Dec 31, 2013 | 63.40% |
| Sep 30, 2013 | -40.53% |
| Jun 30, 2013 | 66.12% |
| Mar 31, 2013 | -29.82% |
| Dec 31, 2012 | 35.20% |
| Sep 30, 2012 | -28.32% |
| Jun 30, 2012 | 43.84% |
| Mar 31, 2012 | -43.77% |